A randomized, single-blind, single-dose, parallel-group study in healthy subjects to demonstrate the pharmacokinetic equivalence of trastuzumab and its biosimilar.
Expert opinion on drug metabolism & toxicology（2023）
摘要
This trial was registered at the [anonymized].
更多查看译文
关键词
trastuzumab,pharmacokinetic equivalence,single-blind,single-dose,parallel-group
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要